1Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, et al. (2009) Deaths: final data for 2006. Natl Vital Stat Rep 57: 1-134.

2Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287: 2570-2581.

3Hink U, Li H, Mollnau H, Oelze M, Matheis E, et al., (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: 14-22.

4Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695.

5Stoll G, Bendszus M (2006) Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37: 1923-1932.

6Mayer K, Merfels M, Muhly-Reinholz M, Gokorsch S, Rosseau S, et al. (2002) Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am J Physiol Heart Circ Physiol 283: 811-818.

7Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, et al. (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23: 622-629.

8Vlahopoulos S, Boldogh I, Casola A, Brasier AR (1999) Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 94: 1878-1889.

9Huber AR, Kunkel SL, Todd RF , Weiss SJ (1991) Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254: 99-102.

10Hashimoto S, Gon Y, Matsumoto K, Takeshita I, Horie T (2001) N-acetylcysteine attenuates TNF-alpha-induced p38 MAP kinase activation and p38 MAP kinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br J Pharmacol,. 132: 270-276.

11 DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, et al. (1993) Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem,. 268: 25568-25576.

12 Krykbaev, R., Krykbaev R, Fitz LJ, Reddy PS, Winkler A, Xuan D, et al. (2010) Evolutionary and biochemical differences between human and monkey acidic mammalian chitinases. Gene 452: 63-71.

13Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, et al. (2011) Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 2011: 479-501.

14Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, et al. (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304: 1678-1682.

15Homer RJ, Zhu Z, Cohn L, Lee CG, White WI, et al. (2006) Differential expression of chitinases identify subsets of murine airway epithelial cells in allergic inflammation. Am J Physiol Lung Cell Mol Physiol 291: 502-511.

16 Bierbaum S, Nickel R, Koch A, Lau S, Deichmann KA, et al. (2005) Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am J Respir Crit Care Med 172: 1505-1509.

17 Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, et al. (2007) A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 357: 2016-2027.

18Yang CJ, Liu YK, Liu CL, Shen CN, Kuo ML, et al. (2009) Inhibition of acidic mammalian chitinase by RNA interference suppresses ovalbumin-sensitized allergic asthma. Hum Gene Ther 20: 1597-1606.

19Kawada M, Hachiya Y, Arihiro A, Mizoguchi E (2007) Role of mammalian chitinases in inflammatory conditions. Keio J Med 56: 21-7.

20Floreani M., Napoli E, Palatini, (2000) Protective action of cardiac DT-diaphorase against menadione toxicity in guinea pig isolated atria. Biochem Pharmacol,. 60: 601-605.

21Cao Z, Li Y (2004) Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol 489: 39-48.

22Yang CJ, Lin CY, Hsieh TC, Olson SC, Wu JM, et al. (2011) Control of eotaxin-1 expression and release by resveratrol and its metabolites in culture human pulmonary artery endothelial cells. Am J Cardiovasc Dis 201: 16-30.

23Hsieh TC, Huang YC, Wu JM, (2011) Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro. Carcinogenesis 32: 93-101.

24Avellone G, Di Garbo V, Campisi D, De Simone R, Raneli G, et al. (2006) Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. Eur J Clin Nutr 60: 41-47.

25Romero-Pérez AI, Ibern-Gómez M, Lamuela-Raventós RM, de La Torre-Boronat MC, et al. (1999) Piceid, the major resveratrol derivative in grape juices. J Agric Food Chem 47: 1533-1536.

26Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK, et al. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32: 1377-1382.

27Kuhnle G, Spencer JP, Chowrimootoo G, Schroeter H, Debnam ES, et al. (2000) Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 272: 212-217.

28Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, et al. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16: 1246-1252.

29Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, et al. (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70: 7392-7399.

30Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, et al. (2006) Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol 291: 1694-1699.

31Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S, et al. (2002) Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J Immunol 169: 6490-6497.

32Zhu H, Li Y (2012) NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions. Cardiovasc Toxicol 12: 39-45.

33Siegel D, Ross D, (2000) Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med 29: 246-53.

34Bertelli AA, Giovannini L, Stradi R, Urien S, Tillement JP, et al. (1996) Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats. Int J Clin Pharmacol Res 1996. 16: 77-81.

35Juan ME, Lamuela-Raventós RM, de la Torre-Boronat MC, Planas JM (1999) Determination of trans-resveratrol in plasma by HPLC. Anal Chem 71: 747-750.

36Juan ME, Planas JM, (2002) Trans-resveratrol oral administration does not affect the enzymatic activities in rat small intestine. J Physiol Biochem,. 58: 59-60.

37Juan ME, Vinardell MP, Planas JM, (2002) The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 132: 257-260.

38Goldberg DM, Yan J, Soleas GJ (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36: 79-87.

39Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, et al. (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70: 7392-7399.

40Wenzel E, Soldo T, Erbersdobler H, Somoza V (2005) Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 49: 482-494.

41Wenzel E, Somoza V (2005) Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 49: 472-481.